Design of Microbiome Immuno-oncology Therapy From Mechanistic Principles

Time: 1:00 pm
day: Day Two – Track B – 1

Details:

• Microbiome is associated with response to ICI therapy in GI tumor patients
• Cross reactive antigens (CRAgs) between microbiota and tumor are associated with patient response to ICI therapy
• CRAgs quality, such as overlap with virulence factors, are associated with patient response

Speakers: